Alpha Governance Record
- Record version
- public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce
- Last updated
- Oct 6, 2026
- Completeness
- 36%
- Record Quality
- 83 / 100
- Evidence coverage
- 4
- Verification status
- Source reported
- Directors
- 12
- Committees
- 0
- Governance events
- 7
Alpha ID: alpha:company:61b74e87-6dde-4a9c-8a56-7acdd43e3f42Schema: alpha-governance-record-v2Ontology: alpha-governance-ontology-v122 published Claims4 sources
Governance at a glance
Each value is read from the published Record. “Not published” means no evidence-backed Claim exists in this Record yet; it is never a finding about the company.
- Board size
- 6Published current seats
- Independence
- Not published
- CEO and chair
- SeparateChair: Frank Verwiel, M.D.
- Lead independent director
- Not published
- Key committees
- Not published
- Ownership concentration
- Not published
- Auditor
- Not published
- Recent governance changes
- 7 derived eventsDIRECTOR APPOINTED
- Shareholder dissent
- Not published
- AI oversight
- Not published
- Cyber oversight
- Not published
- Material legal matters
- Not published
- Alpha Verify status
- Source reportedIdentity: unclaimed
- Record Quality
- 83 / 100Describes Alpha's Record, not the company
Governance record
Record overview
Explore Intellia Therapeutics, Inc.'s published governance Claims, committee structure, and linked sources. Each item reflects the scope and dates of its source.
About this record →- Company
- Intellia Therapeutics, Inc.
- Published Claims
- 22
- Evidence records
- 4
- Record version
- public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce
Record highlights
Only published Claims appear in these highlights.
Shareholders →
No source-linked Claim published yet.
Compensation →
No source-linked Claim published yet.
Legal →
No source-linked Claim published yet.
Committee overview
Committee summaries link to the published Claim and its source evidence.
A committee summary is not published in this record. Review the Board section for available leadership and appointment Claims.
Key governance topics
Counts describe published Claims in this record.
Key Claims
What changed
- DIRECTOR APPOINTED: Brian Goff seat on Intellia Therapeutics, Inc., effective 2026-04-30.Apr 30, 2026
- DIRECTOR APPOINTED: By Mail seat on Intellia Therapeutics, Inc., effective 2026-04-30.Apr 30, 2026
- DIRECTOR APPOINTED: Frank Verwiel seat on Intellia Therapeutics, Inc., effective 2026-04-30.Apr 30, 2026
Board
Published board seats, independence determinations, tenure and committee roles.
- Published seats
- 6Alpha-calculated metric · Count of published current board seats in this Record. Roster completeness is not asserted.
- Independent share
- Not published
- Average tenure
- 3.1 years (6 dated)Alpha-calculated metric · Average tenure at the Record as-of time, bounded by appointment end dates; directors without a published start date are excluded.
- Committee load
- Not published
| Director | Role | Independent | Since | Committees | Status | Claim |
|---|---|---|---|---|---|---|
| Brian Goff | Director | Not published | 2026-04-30 | Not published | Current | Evidence |
| By Mail | Director | Not published | 2026-04-30 | Not published | Current | Evidence |
| Frank Verwiel | Director | Not published | 2026-04-30 | Not published | Current | Evidence |
| Jesse Goodman | Director | Not published | 2018-01-01 | Not published | Current | Evidence |
| Muna Bhanji | Director | Not published | 2022-01-01 | Not published | Current | Evidence |
| William Chase | Director | Not published | 2023-01-01 | Not published | Current | Evidence |
| Frank Verwiel, M.D.Board chair | Chairperson of the Board | YesBoard determination | Not published | Not published | Status not published | Evidence |
| Fred Cohen, M.D., D.Phil. | Director | YesBoard determination | Not published | Not published | Status not published | Evidence |
| Georgia Keresty, Ph.D., M.P.H. | Director | YesBoard determination | Not published | Not published | Status not published | Evidence |
| Jesse Goodman, M.D., M.P.H. | Director | YesBoard determination | Not published | Not published | Status not published | Evidence |
| John M. Leonard, M.D. | President and Chief Executive Officer | NoBoard determination | Not published | Not published | Status not published | Evidence |
| Muna Bhanji, R.Ph. | Director | YesBoard determination | Not published | Not published | Status not published | Evidence |
Skills matrix
Cells show published skill Claims. A blank cell means no Claim is published, not that the director lacks the skill.
| Director | Financial | AI | Cyber | Regulatory | International | Public company | Technology |
|---|---|---|---|---|---|---|---|
| Brian Goff | Not published | Not published | Not published | Not published | Not published | Not published | Not published |
| By Mail | Not published | Not published | Not published | Not published | Not published | Not published | Not published |
| Frank Verwiel | Not published | Not published | Not published | Not published | Not published | Not published | Not published |
| Jesse Goodman | Not published | Not published | Not published | Not published | Not published | Not published | Not published |
| Muna Bhanji | Not published | Not published | Not published | Not published | Not published | Not published | Not published |
| William Chase | Not published | Not published | Not published | Not published | Not published | Not published | Not published |
| Frank Verwiel, M.D. | Not published | Not published | Not published | Not published | Not published | Not published | Not published |
| Fred Cohen, M.D., D.Phil. | Not published | Not published | Not published | Not published | Not published | Not published | Not published |
| Georgia Keresty, Ph.D., M.P.H. | Not published | Not published | Not published | Not published | Not published | Not published | Not published |
| Jesse Goodman, M.D., M.P.H. | Not published | Not published | Not published | Not published | Not published | Not published | Not published |
| John M. Leonard, M.D. | Not published | Not published | Not published | Not published | Not published | Not published | Not published |
| Muna Bhanji, R.Ph. | Not published | Not published | Not published | Not published | Not published | Not published | Not published |
No director skill Claims are published in this Record yet.
Not published in this Record: lead independent director, board type, median tenure, average age, refreshment rate, gender diversity, geographic diversity, succession risk, overboarding, board interlocks, attendance.
Published Claims in this section (12)
Committees
Committees are governed objects with temporal memberships, chairs and mandates.
Committees coverage
No published Claims are available in this section of the public record. This does not establish that the information is undisclosed or that no relevant facts exist.
Review evidence coverageLeadership
Executive roles as published; role codes are title normalizations, not inferences about authority.
| Executive | Title | Role | Start | Status | Board | Claim |
|---|---|---|---|---|---|---|
| Bradley T. Sheares, Ph.D. | Named Executive Officer | Not classified | 2026-04-30 | Current | Not published | Evidence |
| Birgit Schultes, Ph.D. | Executive Vice President, Chief Scientific Officer | Not classified | Not published | Status not published | Not published | Evidence |
| David Lebwohl, M.D. | Executive Vice President, Chief Medical Officer | Not classified | Not published | Status not published | Not published | Evidence |
| Edward J. Dulac III | Executive Vice President, Chief Financial Officer and Treasurer | CFO | Not published | Status not published | Not published | Evidence |
| James Basta, J.D. | Executive Vice President, General Counsel and Corporate Secretary | GC | Not published | Status not published | Not published | Evidence |
| John M. Leonard, M.D. | President and Chief Executive Officer | CEO | Not published | Status not published | Director | Evidence |
- CEO
- John M. Leonard, M.D.
- CFO
- Edward J. Dulac III
- GC
- James Basta, J.D.
- CORPORATE_SECRETARY
- Not published
- COO
- Not published
- CHRO
- Not published
- CIO
- Not published
- CTO
- Not published
- CISO
- Not published
- CAIO
- Not published
- CRO
- Not published
Published Claims in this section (6)
Ownership
Holders, voting power and activism as disclosed. Influence is never inferred from ownership alone.
Activist positions
No activist positions are published in this Record.
Ownership disclosures
No ownership disclosures are published in this Record.
Ownership coverage
No published Claims are available in this section of the public record. This does not establish that the information is undisclosed or that no relevant facts exist.
Review evidence coverageFinancials
Governance-relevant financial context with period, unit and source attached to each observation.
Published financial observations retain their reported values, periods, and sources. Coverage may be partial; this is not a reconstructed complete financial statement.
All financials coverage
No published Claims are available in this section of the public record. This does not establish that the information is undisclosed or that no relevant facts exist.
Review evidence coverageOther published Claims in this section (1)
Governance
Governing documents, provisions and shareholder meeting records as versioned policy objects.
Provisions
No charter or bylaw provisions are published in this Record.
Shareholder meetings and votes
No shareholder meeting or vote records are published in this Record.
Governance coverage
No published Claims are available in this section of the public record. This does not establish that the information is undisclosed or that no relevant facts exist.
Review evidence coverageRisk
Risk ownership, audit and assurance, and cyber oversight. Company assertions, independent assurance and Alpha verification stay distinct.
No risk disclosures are published in this Record yet.
Governed risk taxonomy
strategic · financial · operational · legal · regulatory · cyber · privacy · ai · model · agentic · supply_chain · geopolitical · climate · human_capital · reputation · third_party · concentration
Audit and assurance
- External auditor
- Not published
- Auditor tenure
- Not published
- Engagement partner
- Not published
- Alpha verification
- source reported Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed.
Material weaknesses and restatements
No material weakness or restatement is published in this Record. This is not a clean-controls conclusion.
Independent assurance
No independent assurance report is published in this Record.
Company assertions
No company assurance assertions are published in this Record.
Cybersecurity and data governance
- Executive owner
- Not published
- Board oversight
- Not published
Cyber and privacy incidents
No cyber or privacy incident is published in this Record. Absence of a disclosure is not absence of an incident.
No further cyber or data governance disclosures are published.
Agent governance
Restricted Agent Deployments, Agent Use Cases, Authority Grants, TrustChecks, Action Ledger entries and Governance Receipts live in the private enterprise overlay. They are never projected into the public Registry without explicit cross-plane authorization. Absence here is a plane boundary, not evidence that the enterprise operates no agents.
transaction_schema_version=2026-08-29 authority_object=AuthorityGrant pre_action_decision=TrustCheck action_record=GovernanceReceipt plane=private_enterprise_overlay
Risk coverage
No published Claims are available in this section of the public record. This does not establish that the information is undisclosed or that no relevant facts exist.
Review evidence coverageAI
Board and executive oversight of AI, AI policies, incidents and regulation exposure.
- Executive AI owner
- Not published
- Board or committee AI oversight
- Not published
- Responsible AI committee
- Not published
- AI governance framework
- Not published
- Model inventory
- Restricted Private enterprise overlay
AI incidents
No AI incident is published in this Record. Absence of a disclosure is not absence of an incident.
External AI assurance
No external AI assurance is published in this Record.
AI regulation exposure
No AI regulation exposure disclosure is published in this Record.
Other AI governance disclosures
No further AI governance disclosures are published.
AI coverage
No published Claims are available in this section of the public record. This does not establish that the information is undisclosed or that no relevant facts exist.
Review evidence coverageLegal
Litigation, regulatory investigations and enforcement as first-class legal matters.
Legal developments
No legal developments are published in this Record.
Legal coverage
No published Claims are available in this section of the public record. This does not establish that the information is undisclosed or that no relevant facts exist.
Review evidence coverageCompensation
Executive and director compensation disclosures and metrics.
No compensation disclosures are published in this Record.
Compensation coverage
No published Claims are available in this section of the public record. This does not establish that the information is undisclosed or that no relevant facts exist.
Review evidence coverageGovernance events
Events are derived from dated changes in governed relationships and from Registry record supersession. Nothing here is typed by hand.
- 2026-04-30DIRECTOR APPOINTEDBrian Goff seat on Intellia Therapeutics, Inc., effective 2026-04-30.Temporal change
- 2026-04-30DIRECTOR APPOINTEDBy Mail seat on Intellia Therapeutics, Inc., effective 2026-04-30.Temporal change
- 2026-04-30DIRECTOR APPOINTEDFrank Verwiel seat on Intellia Therapeutics, Inc., effective 2026-04-30.Temporal change
- 2026-04-30EXECUTIVE APPOINTEDBradley T. Sheares, Ph.D. executive of Intellia Therapeutics, Inc., effective 2026-04-30.Temporal change
- 2023-01-01DIRECTOR APPOINTEDWilliam Chase seat on Intellia Therapeutics, Inc., effective 2023-01-01.Temporal change
- 2022-01-01DIRECTOR APPOINTEDMuna Bhanji seat on Intellia Therapeutics, Inc., effective 2022-01-01.Temporal change
- 2018-01-01DIRECTOR APPOINTEDJesse Goodman seat on Intellia Therapeutics, Inc., effective 2018-01-01.Temporal change
Evidence, history and coverage
Additional published Claims
Published evidence records
4 evidence records, matching Agent View. Records may refer to different locations or observations in the same document. This count is not a count of independent corroborating sources.
Alpha canonical company public projection
canonical identity · Source published: Date unavailable · Retrieved: Oct 5, 2026
Supports 4 claims
- Legal Name: Intellia Therapeutics, Inc. · Claim reviewed: Oct 5, 2026
- Entity Status: Public listing published · Claim reviewed: Oct 5, 2026
- Published Fact: US · Claim reviewed: Oct 5, 2026
- Security Listing: NTLA (NASDAQ) · Claim reviewed: Oct 5, 2026
SEC DEF 14A 0001193125-26-197283
sec def 14a · Source published: Apr 30, 2026 · Retrieved: Sep 12, 2026
Supports 11 claims
- Leadership Role: Frank Verwiel, M.D.: Chairperson of the Board · Claim reviewed: Oct 5, 2026
- Leadership Role: Fred Cohen, M.D., D.Phil.: Director · Claim reviewed: Oct 5, 2026
- Leadership Role: Georgia Keresty, Ph.D., M.P.H.: Director · Claim reviewed: Oct 5, 2026
- Leadership Role: Jesse Goodman, M.D., M.P.H.: Director · Claim reviewed: Oct 5, 2026
- Leadership Role: John M. Leonard, M.D.: President and Chief Executive Officer · Claim reviewed: Oct 5, 2026
- Leadership Role: Muna Bhanji, R.Ph.: Director · Claim reviewed: Oct 5, 2026
- Leadership Role: Birgit Schultes, Ph.D.: Executive Vice President, Chief Scientific Officer · Claim reviewed: Oct 5, 2026
- Leadership Role: David Lebwohl, M.D.: Executive Vice President, Chief Medical Officer · Claim reviewed: Oct 5, 2026
- Leadership Role: Edward J. Dulac III: Executive Vice President, Chief Financial Officer and Treasurer · Claim reviewed: Oct 5, 2026
- Leadership Role: James Basta, J.D.: Executive Vice President, General Counsel and Corporate Secretary · Claim reviewed: Oct 5, 2026
- Leadership Role: John M. Leonard, M.D.: President and Chief Executive Officer · Claim reviewed: Oct 5, 2026
DEF 14A ntla-20260430.htm
sec proxy · Source published: Apr 30, 2026 · Retrieved: Sep 2, 2026
Supports 6 claims
- Leadership Role: Brian Goff: Director · Claim reviewed: Oct 5, 2026
- Leadership Role: By Mail: Director · Claim reviewed: Oct 5, 2026
- Leadership Role: Frank Verwiel: Director · Claim reviewed: Oct 5, 2026
- Leadership Role: Jesse Goodman: Director · Claim reviewed: Oct 5, 2026
- Leadership Role: Muna Bhanji: Director · Claim reviewed: Oct 5, 2026
- Leadership Role: William Chase: Director · Claim reviewed: Oct 5, 2026
NTLA DEF 14A executive officers
sec filing · Source published: Apr 30, 2026 · Retrieved: May 5, 2026
Supports 1 claim
- Leadership Role: Bradley T. Sheares, Ph.D.: Named Executive Officer · Claim reviewed: Oct 5, 2026
- 2026-04-30DIRECTOR APPOINTEDBrian Goff seat on Intellia Therapeutics, Inc., effective 2026-04-30.Temporal change
- 2026-04-30DIRECTOR APPOINTEDBy Mail seat on Intellia Therapeutics, Inc., effective 2026-04-30.Temporal change
- 2026-04-30DIRECTOR APPOINTEDFrank Verwiel seat on Intellia Therapeutics, Inc., effective 2026-04-30.Temporal change
- 2026-04-30EXECUTIVE APPOINTEDBradley T. Sheares, Ph.D. executive of Intellia Therapeutics, Inc., effective 2026-04-30.Temporal change
- 2023-01-01DIRECTOR APPOINTEDWilliam Chase seat on Intellia Therapeutics, Inc., effective 2023-01-01.Temporal change
- 2022-01-01DIRECTOR APPOINTEDMuna Bhanji seat on Intellia Therapeutics, Inc., effective 2022-01-01.Temporal change
- 2018-01-01DIRECTOR APPOINTEDJesse Goodman seat on Intellia Therapeutics, Inc., effective 2018-01-01.Temporal change
Identity
unclaimed
Evidence
source reported
Evaluation
not evaluated
Monitoring
Unknown
Authority
Unknown
Freshness
current
Section coverage
Completeness 36% of expected sections for a public company. States describe Alpha's Record, not the company. Missing expected sections: corporate_structure, committees, ownership, financials, compensation, governance, shareholder_governance, audit, legal, risk, cyber, ai_governance, markets_external.
- Identity
- Published
- Corporate structure
- Not reviewed
- Board
- Published
- Committees
- Not reviewed
- Leadership
- Published
- Ownership and shareholders
- Not reviewed
- Financials
- Not reviewed
- Capital structure
- Published
- Compensation
- Not reviewed
- Governance
- Not reviewed
- Shareholder governance
- Not reviewed
- Audit and assurance
- Not reviewed
- Legal and regulatory
- Not reviewed
- Risk
- Not reviewed
- Cybersecurity and data governance
- Not reviewed
- AI governance
- Not reviewed
- Agent governance
- Restricted
- Markets and external ecosystem
- Not reviewed
- Governance events
- Published
- Relationships
- Published
- Assessments and Evals
- Published
- Evidence
- Published